Form D · Venture Capital Fund

Curie Bio Series A Fund I, L.P.

Cambridge, MA · CIK 0002009749

Offering snapshot reported Jun 26, 2024 · SEC filing

Reported sold
$377M
Offering amount: $377M
Investors reported
48
Form D · investor count
Minimum accepted
$0
Reported outside-investor minimum
First sale
Feb 29, 2024
As reported in this filing

What changed?

Latest filing versus its linked predecessor, where available.

  • Reported investors0 → 48

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
Jun 26, 2024Amendment$376,725,000No comparison48SEC filing
Feb 28, 2024InitialYet to sellNo comparison0SEC filing

Offering details

Securities
Pooled investment fund
Exemptions
06b, 3C, 3C.7
Duration over one year
No
Business combination
No
Sales commissions
$0
Finders' fees
$0
Form D file number
021-506345

Source: Form D, filed Jun 26, 2024. Minimum accepted may differ from a standard advertised minimum.

Fund connections

The linked fund shows its most recently reported ADV details.

Matched by reported Form D file number

CURIE BIO SERIES A FUND I, L.P.

Investment adviser: CURIE BIO OPERATIONS, LLC

Gross asset value
$379M
Beneficial owners
48
ADV minimum commitment
$0

Reported in Form ADV on Mar 20, 2026. Fund assets and beneficial owners measure different things from Form D sales and investors.

Service providers

Fund administrator STANDISH MANAGEMENT, LLC BOSTON, Massachusetts, United States Investor statements: Yes (provided to all investors) Related to adviser: No
Auditor FRANK, RIMERMAN + CO. LLP SAN FRANCISCO, California, United States
Custodian JPMORGAN CHASE BANK NA BOSTON, Massachusetts, United States Related to adviser: No
Provider details
Annual audit
Yes
Prime brokers
No
Custodians
Yes
Administrator other than the adviser
Yes
External marketing
No

FRANK, RIMERMAN + CO. LLP
PCAOB 1596

JPMORGAN CHASE BANK NA
LEI 7H6GLXDRUGQFU57RNE97

Filing source

Form ADV 2047678 · Mar 20, 2026 · Schedule D 7.B.(1), fund 805-5856049760

Official IAPD profile (latest public filing). Values are the most recently reported in our imported data; the public profile may show a newer filing.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
Alexis Borisy Executive
N/A Curie Bio Investments, Llc Executive
N/A Curie Bio, Llc Executive
N/A Curie Bio Series A Gp I, L.L.C. Executive
Zachary Weinberg Executive

Issuer details

Industry: Pooled Investment Fund (See others in industry)

Address:
196 Broadway, 1 St Floor
Cambridge, MA, 02139